Inventor · disambiguated record
Remy Gebleux
Also filed as: GEBLEUX REMY · GEBLEUX RÉMY · GÉBLEUX RÉMY
3 granted patents·1 pending application·8 citations·filing 2017–2022
57Inventor score
Top patents by PatentIndex Score
4 records- 0189US10758556B2Anthracycline-based antibody drug conjugates having high in vivo tolerabilityNBE THERAPEUTICS AG·Filed 2019·Granted Sep 1, 2020·8 cites·31 claims
- 0258US12121527B2Anthracycline-based antibody drug conjugates having high in vivo tolerabilityNBE THERAPEUTICS AG·Filed 2020·Granted Oct 22, 2024·0 cites·19 claims
- 0352US10906963B2Non-glycosylated anti-tenascin antibodyPHILOGEN SPA·Filed 2017·Granted Feb 2, 2021·0 cites·21 claims
- 0448US2024158435A1Biocatalytical composition and use for generation of immunoligand-payload conjugatesINOFEA AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Remy Gebleux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →